The Quantify Glaucoma Clinical Outcomes Database is developed to document clinical safety and efficacy information from all randomized placebo and active controlled trials in patients with ocular hypertension or (open angle) glaucoma treated with latanoprost, bimatoprost, travoprost, tafluprost, dorzolamide, brinzolamide or timolol (timolol is included as control only). Trials in the database also include washout designs and add on designs.
The current version of the database includes clinical safety and efficacy information on all biologics as well as newer synthetic DMARDs currently approved or in development for rheumatoid arthritis (RA). Information on older treatment options (MTX and other DMARDs) was included if they are used as active controls.
The current version of the database includes clinical safety and efficacy information on treatment options currently approved or in development for Chronic Kidney Disease (CKD) progression
in patients with Type 2 Diabetes Mellitus (T2DM) and overt albuminuria/proteinuria, as well as patients with IGA nephropathy.
The current version of the database contains information from randomized controlled trails on all current biologic and small molecule drugs that are evaluated for moderate-to-severe Crohn’s disease in patients that failed conventional treatment.
The Quantify AS Clinical Outcomes Database is developed to document clinical safety and efficacy information from randomized controlled trials investigating biologics currently approved or in development for ankylosing spondylitis (AS).
The Quantify Acute Lymphoblastic Leukemia (ALL) Clinical Outcomes Database documents clinical efficacy information in infants, children, and adults following salvage treatment for relapsed/refractory patients.
The current version of the database includes clinical safety and efficacy information on all symptomatic drugs as well as newer Abeta drugs currently approved or in development for Alzheimer Disease (AD).
The Quantify Major Depression Disorder (MDD) Clinical Outcomes Database documents clinical efficacy and safety information from randomized and controlled regulatory trials investigating monotherapy and adjunctive therapy pharmaceutical drugs for major depression disorder and treatment-resistant depression.
